Atıf Formatları
Novel spiroindoline derivatives targeting aldose reductase against diabetic complications: Bioactivity, cytotoxicity, and molecular modeling studies
  • IEEE
  • ACM
  • APA
  • Chicago
  • MLA
  • Harvard
  • BibTeX

O. Gulec Et Al. , "Novel spiroindoline derivatives targeting aldose reductase against diabetic complications: Bioactivity, cytotoxicity, and molecular modeling studies," BIOORGANIC CHEMISTRY , vol.145, 2024

Gulec, O. Et Al. 2024. Novel spiroindoline derivatives targeting aldose reductase against diabetic complications: Bioactivity, cytotoxicity, and molecular modeling studies. BIOORGANIC CHEMISTRY , vol.145 .

Gulec, O., TÜRKEŞ, C., ARSLAN, M., DEMİR, Y., Dincer, B., Ece, A., ... KÜFREVİOĞLU, Ö. İ.(2024). Novel spiroindoline derivatives targeting aldose reductase against diabetic complications: Bioactivity, cytotoxicity, and molecular modeling studies. BIOORGANIC CHEMISTRY , vol.145.

Gulec, Ozcan Et Al. "Novel spiroindoline derivatives targeting aldose reductase against diabetic complications: Bioactivity, cytotoxicity, and molecular modeling studies," BIOORGANIC CHEMISTRY , vol.145, 2024

Gulec, Ozcan Et Al. "Novel spiroindoline derivatives targeting aldose reductase against diabetic complications: Bioactivity, cytotoxicity, and molecular modeling studies." BIOORGANIC CHEMISTRY , vol.145, 2024

Gulec, O. Et Al. (2024) . "Novel spiroindoline derivatives targeting aldose reductase against diabetic complications: Bioactivity, cytotoxicity, and molecular modeling studies." BIOORGANIC CHEMISTRY , vol.145.

@article{article, author={Ozcan Gulec Et Al. }, title={Novel spiroindoline derivatives targeting aldose reductase against diabetic complications: Bioactivity, cytotoxicity, and molecular modeling studies}, journal={BIOORGANIC CHEMISTRY}, year=2024}